Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chorioallantoic Membrane | 2 | 2024 | 12 | 1.000 |
Why?
|
| Chickens | 1 | 2022 | 636 | 0.730 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 63 | 0.590 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 5 | 0.500 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2015 | 292 | 0.480 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 794 | 0.470 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 478 | 0.460 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 877 | 0.460 |
Why?
|
| Epithelial Cells | 2 | 2015 | 909 | 0.420 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1496 | 0.370 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2513 | 0.340 |
Why?
|
| Cell Proliferation | 2 | 2015 | 2311 | 0.310 |
Why?
|
| Chick Embryo | 2 | 2024 | 131 | 0.240 |
Why?
|
| Heterografts | 2 | 2022 | 173 | 0.230 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2019 | 557 | 0.220 |
Why?
|
| Signal Transduction | 2 | 2015 | 4534 | 0.220 |
Why?
|
| Anoctamin-1 | 1 | 2022 | 3 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 4396 | 0.190 |
Why?
|
| Receptor, ErbB-2 | 1 | 2024 | 515 | 0.180 |
Why?
|
| Cisplatin | 1 | 2022 | 249 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 620 | 0.170 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 460 | 0.160 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 62 | 0.160 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 25 | 0.160 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 88 | 0.150 |
Why?
|
| Mice | 6 | 2024 | 17635 | 0.150 |
Why?
|
| Smoothened Receptor | 2 | 2015 | 27 | 0.150 |
Why?
|
| Urinary Bladder | 1 | 2019 | 242 | 0.150 |
Why?
|
| Animals | 7 | 2024 | 34238 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 832 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2022 | 667 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 503 | 0.140 |
Why?
|
| Breast | 1 | 2018 | 213 | 0.140 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 257 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2019 | 344 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2174 | 0.130 |
Why?
|
| Estrogens | 1 | 2018 | 504 | 0.130 |
Why?
|
| Progesterone | 1 | 2018 | 623 | 0.130 |
Why?
|
| Disease Progression | 2 | 2019 | 2067 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2024 | 889 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1101 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1691 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2397 | 0.100 |
Why?
|
| Drosophila | 1 | 2015 | 774 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 3348 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2011 | 69 | 0.090 |
Why?
|
| Humans | 8 | 2024 | 125269 | 0.080 |
Why?
|
| Female | 5 | 2024 | 66844 | 0.060 |
Why?
|
| Risk Factors | 1 | 2018 | 10319 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1898 | 0.050 |
Why?
|
| RNA Editing | 1 | 2001 | 34 | 0.050 |
Why?
|
| Chloride Channels | 1 | 2022 | 62 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2001 | 134 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2001 | 195 | 0.040 |
Why?
|
| Lysosomes | 1 | 2022 | 237 | 0.040 |
Why?
|
| Zebrafish | 1 | 2022 | 379 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 21 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 43 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 53 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 137 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 91 | 0.040 |
Why?
|
| Nucleotides | 1 | 2019 | 92 | 0.040 |
Why?
|
| Swine | 1 | 2022 | 1210 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 359 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 272 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2001 | 573 | 0.030 |
Why?
|
| Cell Line | 1 | 2022 | 2756 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 293 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1726 | 0.030 |
Why?
|
| Metabolomics | 1 | 2019 | 423 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3727 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1275 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2820 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2011 | 699 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 678 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2062 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 955 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1894 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2011 | 208 | 0.020 |
Why?
|
| Cell Communication | 1 | 2011 | 167 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2011 | 187 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 159 | 0.020 |
Why?
|
| Neoplasms | 1 | 2024 | 2790 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 320 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 201 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1314 | 0.020 |
Why?
|
| Macrophages | 1 | 2011 | 626 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2001 | 9 | 0.010 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2001 | 22 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 96 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2001 | 161 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 4262 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 156 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2001 | 167 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 282 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 658 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 388 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 897 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 772 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 2714 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 3892 | 0.010 |
Why?
|
| Male | 1 | 2019 | 61560 | 0.010 |
Why?
|